Outcome of patients treated for tuberculosis in Vaud County, Switzerland

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 5, 1998, Pages 372-377

  Zellweger, J P ^a   Coulon, P ^a  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

Author keywords

Adherence; Directly observed treatment; Outcome of treatment; Surveillance; Tuberculosis

Indexed keywords

ALCOHOLISM; ARTICLE; EDUCATION PROGRAM; HUMAN; HUMAN TISSUE; IMMIGRANT; INCIDENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SOCIOECONOMICS; SWITZERLAND; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0031815108     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Grzybowski S, Enarson D. The fate of cases of pulmonary tuberculosis under various treatment programmes. Bull Int Union Tuberc 1978; 53(2): 70-75.
2. Frieden T R, Sterling T, Pablos-Mendez A, Kilburn J O, Cauthen G M, Dooley S W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-526.
3. Rodier G R, Gravier P, Sèvre J P, Binson G, Omar C S. Multidrug-resistant tuberculosis in the Horn of Africa. J Infect Dis 1993; 168: 523-524.
4. Datta M, Radhmani M P, Selvaraj R, et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tubercle Lung Dis 1993; 74: 180-186.
5. World Health Organization. Treatment of tuberculosis. Guidelines for National Programmes. Geneva, Switzerland: WHO, 1993.
6. Pablos-Mendez A, Knirsch C A, Barr G, Lerner B H, Frieden T R. Non-adherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med 1997; 102: 164-170.
7. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis 1993; 147: 1311-1320.
8. Menzies R, Rocher I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tubercle Lung Dis 1993; 74: 32-37.
9. Sudre P, Hirschel B, Toscani L, Ledergerber B, Rieder H L, Swiss HIV Cohort Study. Risk factors for tuberculosis among HIV-infected patients in Switzerland. Eur Respir J 1996; 9: 279-283.
10. Helbling P, Zellweger J P. TB drug resistance surveillance in Switzerland. Int J Tuberc Lung Dis 1997; 1(Suppl): S27.
11. Rothe T B, Karrer W. Short-course treatment of pulmonary tuberculosis: doctor's compliance. Tubercle Lung Dis 1996; 77: 93-97.
12. Manalo F, Tan F, Sbarbaro J A, Iseman M D. Community based short-course treatment of pulmonary tuberculosis in a developing nation: initial report of an eight-month, largely intermittent, regimen in a population with a high prevalence of drug resistance. Am Rev Respir Dis 1990; 142: 1301-1305.
13. Frieden T R, Fujiwara P I, Washko R M, Hamburg M A. Tuberculosis in New York City - turning the tide. N Engl J Med 1995; 333: 229-233.
14. Weis S E, Slocum P C, Blais F X, et al. The effect of directly observed treatment on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-1184.
15. Shang H, Rose N, Pfyffer G, Oggier W, Brändli O. Cohort analysis of a primary care physician based TB control program in the canton of Zurich, Switzerland, 1991-1993. Schweiz Med Wochenschr 1996; 126, 74(Suppl 1): 17S.
16. Association suisse contre la tuberculose et les maladies pulmonaires (ASTP). Lignes directrices pour le traitement de la tuberculose. Bull Féd Santé Publ 1996; 16: 9-13.